232596-78-0

Basic information

• Product Name: di-tert-butyl (S)-2-(2-{[2-(3-benzyl-ureido)-thiazol-4-carbonyl]-amino}-acetylamino)-succinate
• CAS NO: 232596-78-0
• Molecular Weight: 561.659
• Mol File: 232596-78-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: di-tert-butyl (S)-2-(2-{[2-(3-benzyl-ureido)-thiazol-4-carbonyl]-amino}-acetylamino)-succinate(CAS DataBase Reference)
• NIST Chemistry Reference: di-tert-butyl (S)-2-(2-{[2-(3-benzyl-ureido)-thiazol-4-carbonyl]-amino}-acetylamino)-succinate(232596-78-0)
• EPA Substance Registry System: di-tert-butyl (S)-2-(2-{[2-(3-benzyl-ureido)-thiazol-4-carbonyl]-amino}-acetylamino)-succinate(232596-78-0)

Safety Data

• Hazardous Substances Data: 232596-78-0(Hazardous Substances Data)

Upstream product

• 232595-77-6 [(2-(3-benzyl-ureido)-thiazole-4-carbonyl)-amino]-acetic acid 
• 13795-73-8 L-aspartic acid di-tert-butyl ester 

Relevant articles and documents

Thiazole derivatives

Compounds of the formula: as well as pharmaceutically usable salts and esters thereof, wherein R1, R2and R3have the significance ascribed herein, inhibit binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. These compounds can be used in the form of pharmaceutical preparations for the control or prevention of neoplasms, tumor metastasing, tumor growth, osteoporosis, Paget's disease, diabetic retinopathy, macular degeneration, restenosis following vascular intervention, psoriasis, arthritis, fibrosis, kidney failure, as well as infection caused by viruses, bacteria or fungi.